Moving Beyond Fixed Dosing: Using Quantitative Dosimetry to Deliver Truly Personalised TRP Treatment
Targeted Radiopharmaceuticals Summit EU 2026 · 2 December 2026 · 14:00
Moving Beyond Fixed Dosing: Using Quantitative Dosimetry to Deliver Truly Personalised TRP Treatment was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 2 December 2026 in London, with 1 speaker on record.
Speakers
- David Gauden — Speaker Chief Executive Officer, Blue Earth Therapeutics Ltd.